Humana (HUM) Akcija Kursas
Humana Kursas
Per pastaruosius 19 metus Humana pajamos augo 9,9 % kasmet ir pasiekė 129,66 mlrd. USD. Pelnas akcijai augo 6,7 % per metus per pastaruosius 19 metus. Humana grynoji marža 0,9 % yra sumažėjo palyginti su 3,5 % prieš kelerius metus. Esama kaina dividendo pajamingumas yra apie 0,85 %. Išmokų koeficientas yra apie 36 % pelno. Dividendas augo 11,7 % per metus per pastaruosius 14 metus. Humana 12 mėn. konsensuso tikslinė kaina yra 412,50 USD, apie žemiau kursą 1,3 %. Iš 33 analitikų 16 rekomenduoja pirkti — bendras konsensusas yra Laikyti.
Humana akcijos kaina
Gaukite šiuos duomenis per Eulerpool API
100 000 užklausų/mėn. nemokamai · be kortelės
Humana akcija ir akcijų analizė
Dažnai užduodami klausimai apie Humana akciją
The business model of Humana Inc is focused on providing healthcare services to individuals and families. As a leading health insurance company, Humana offers a wide range of health insurance plans and services including Medicare, Medicaid, and commercial plans. The company aims to improve the health and wellbeing of its members by offering access to quality healthcare, working closely with healthcare providers, and promoting preventive care and wellness programs. With a strong commitment to innovation and technology, Humana strives to enhance the overall healthcare experience for its members while driving value and affordability in healthcare delivery.
Humana Inc is primarily active in the healthcare industry. With a focus on offering a wide range of health insurance products and services, Humana serves individuals, employers, military service members, and their families. The company provides various medical and specialty health products, including Medicare Advantage plans, prescription drug plans, dental, vision, and wellness programs. With an extensive network of healthcare providers, Humana aims to improve the health and well-being of its members by delivering personalized and comprehensive healthcare solutions. As one of the leading healthcare companies, Humana Inc plays a crucial role in the provision of accessible and quality healthcare services.
The main competitors of Humana Inc in the market include UnitedHealth Group Incorporated, Anthem, Inc., and CVS Health Corporation.
Humana Inc is a leading healthcare company founded in 1961 and headquartered in Louisville, Kentucky. With a rich history spanning over five decades, Humana has emerged as a trusted name in the industry. Originally a nursing home business, Humana quickly expanded its operations to provide comprehensive health insurance services. Today, it offers a wide range of healthcare products and services, including Medicare and Medicaid plans, commercial health insurance, and specialty benefits. Through strategic acquisitions and partnerships, Humana has consistently grown its presence, providing innovative and accessible healthcare solutions to millions of customers across the United States. The company's commitment to customer-centric care and its extensive industry experience have solidified Humana Inc's position as a prominent player in the healthcare sector.
Humana Inc, a renowned healthcare company, has achieved several significant milestones throughout its history. One notable achievement was the company's inclusion in the Fortune 500 list, highlighting its position among the top-ranked businesses in the United States. Additionally, Humana Inc has consistently expanded its presence and diversified its offerings, successfully establishing itself as a leading provider of health insurance, wellness programs, and healthcare services. The company has also been recognized for its commitment to innovation, earning accolades for its progressive approach to healthcare delivery. Humana Inc's dedication to improving customer satisfaction and promoting healthy living has contributed to its widespread success in the industry.
Humana Inc is primarily present in the United States.
Humana Inc is committed to enhancing the well-being of people and making healthcare more accessible. The company's corporate philosophy revolves around delivering value-based care, focusing on the whole person, and improving the health outcomes of its members. Humana prioritizes innovation and technology to provide personalized and affordable healthcare solutions. With a focus on preventive care and wellness programs, Humana aims to empower individuals to live healthier lives. By fostering a culture of inclusion, collaboration, and integrity, Humana strives to be a trusted partner for its members, employees, and communities it serves.
Analitikai šiuo metu nustato vidutinę Humana akcijos tikslinę kainą 416,78 USD (mediana: 412,50 USD), t. y. −0,3 % palyginti su paskutine kaina. Konsensusas pagrįstas 33 analitikų reitingais.
33 analitikai šiuo metu vertina Humana akciją: 16 rekomenduoja pirkti, 16 laikyti ir 1 parduoti. 2026 m. analitikai tikisi, kad Humana gaus 162,52 mlrd. USD pajamų ir 9,14 USD pelno akcijai.
Pagal dabartinį kursą Humana akcija kainuoja 371,76 EUR (417,89 USD).
Humana akcija (HUM) kotiruojama 7 biržose, įskaitant: NYSE (HUM), London (0J6Z.L), SIX (Zürich) (HUM.SW), Frankfurt (HUM.F), München (HUM.MU), Düsseldorf (HUM.DU).
Humana Inc is a global healthcare company based in Louisville, Kentucky. It offers various products and services in healthcare, health insurance, and lifelong health solutions. They provide insurance for different areas such as medical, dental, vision, and travel. Additionally, they have specialized insurance plans for seniors and people with chronic illnesses. Humana also operates clinics and medical centers, offering a wide range of medical services including prevention, diagnosis, and treatment. They invest in research and development of medical technologies to improve healthcare. In terms of lifelong health solutions, Humana has programs like Humana GO365 that reward healthy behaviors. They also operate pharmacies and offer specialized pharmacy services. Humana's business model aims to provide tailored health solutions and insurance products to meet each customer's needs.
tikėtina pelnas Humana yra 162,52 mlrd. USD. Šis skaičius grindžiamas dabartiniais finansiniais duomenimis ir atspindi įmonės verslo rezultatus.
tikėtina grynasis pelnas Humana yra 1,10 mlrd. USD. Grynasis pelnas atspindi įmonės pelningumą po visų išlaidų atimties.
Kainų ir nuomos santykis (KGV) Humana šiuo metu yra 45,74. KGV lygina dabartinę akcijos kainą su pelnu už akciją ir padeda investuotojams įvertinti Humana akcijos vertę.
Kainų ir pardavimų santykis (KUV) Humana šiuo metu yra 0,31. KUV lygina rinkos kapitalizaciją su metinėmis pajamomis ir yra Humana akcijos įvertinimo metrika.
Eulerpool kokybės balas Humana yra 5/10.
Humana ISIN yra US4448591028. ISIN (International Securities Identification Number) yra pasaulinė unikali vertybinių popierių identifikacijos sistema.
Humana WKN yra 856584. WKN (Wertpapierkennnummer) yra šešiaženklė vokiška vertybinių popierių identifikacijos sistema.
Humana prekybos žymė yra HUM. Ši biržos žymė naudojama Humana akcijoms prekiauti biržoje.
Humana akcija
Humana Pagrindiniai konkurentai
Humana Biržos simbolis
Humana FIGI
Visos Humana pagrindinės charakteristikos ir giluminė analizė
Mūsų akcijų analizė Humana akcijai apima svarbius finansinius rodiklius, tokius kaip apyvarta, pelnas, P/E santykis, P/S santykis, EBIT, taip pat informaciją apie dividendes. Be to, mes nagrinėjame aspektus, tokius kaip akcijos, rinkos kapitalizacija, skolos, nuosavas kapitalas ir įsipareigojimai Humana. Jei ieškote išsamesnės informacijos šiais klausimais, mūsų poskyriuose galite rasti išsamias analizes: